DiCE Molecules rallies $80m Series A

DiCE Molecules, a biopharmaceutical company, has closed $80 million in Series C financing.

DiCE Molecules, a biopharmaceutical company, has closed $80 million in Series C financing. RA Capital Management led the round.

Source: Press Release